Mirum Pharmaceuticals Ownership | Who Owns Mirum Pharmaceuticals?
Mirum Pharmaceuticals Ownership Summary
Mirum Pharmaceuticals is owned by 111.37% institutional investors, 1.86% insiders. Frazier life sciences management is the largest institutional shareholder, holding 13.66% of MIRM shares. Eventide Gilead N is the top mutual fund, with 2.89% of its assets in Mirum Pharmaceuticals shares.
MIRM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Mirum Pharmaceuticals | 111.37% | 1.86% | -13.24% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 307.00% | 11.11% | -218.12% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 13.66% | $345.80M |
| Janus henderson group | 4.58M | 9.59% | $189.48M |
| Blackrock funding, inc. /de | 3.58M | 7.19% | $182.04M |
| Blackrock | 3.24M | 6.90% | $110.71M |
| Bvf inc/il | 2.76M | 5.55% | $140.52M |
| Eventide asset management | 2.64M | 5.30% | $134.22M |
| Vanguard group | 2.42M | 5.07% | $100.26M |
| State street | 1.50M | 3.19% | $51.16M |
| Novo | 1.50M | 3.02% | $76.34M |
| Price t rowe associates inc /md/ | 1.42M | 2.98% | $58.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Frazier life sciences management | 6.80M | 13.83% | $345.80M |
| Boone capital management | 581.84K | 8.12% | $24.06M |
| Novo | 1.50M | 5.39% | $76.34M |
| Bvf inc/il | 2.76M | 5.02% | $140.52M |
| First turn management | 506.91K | 3.75% | $20.96M |
| Tang capital management | 1.24M | 3.18% | $62.90M |
| Highlander partners | 122.98K | 2.89% | $5.09M |
| Lion point capital, lp | 45.00K | 2.80% | $1.54M |
| Avidity partners management lp | 666.20K | 2.71% | $27.55M |
| Rock springs capital management lp | 818.21K | 2.59% | $41.64M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.24M | 0.00% | 785.78K |
| Jpmorgan chase | 385.14K | 0.00% | 357.38K |
| Emerald advisers | 305.77K | 0.57% | 305.77K |
| Soleus capital management | 298.70K | 1.01% | 298.70K |
| Bnp paribas arbitrage, snc | 261.64K | 0.01% | 261.64K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.50M | 0.00% | -1.33M |
| William blair investment management | - | - | -677.94K |
| Bioimpact capital | - | - | -589.58K |
| Cadian capital management, lp | - | - | -475.71K |
| Checkpoint capital | - | - | -362.19K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Emerald advisers | 305.77K | 0.57% | 305.77K | $15.56M |
| Soleus capital management | 298.70K | 1.01% | 298.70K | $15.20M |
| Bnp paribas arbitrage, snc | 261.64K | 0.01% | 261.64K | $10.82M |
| Eversept partners, lp | 232.18K | 1.09% | 232.18K | $11.82M |
| Emerald mutual fund advisers trust | 217.54K | 0.67% | 217.54K | $11.07M |
Sold Out
| Holder | Change |
|---|---|
| Coldstream capital management | -1.00 |
| Ifp advisors | -3.00 |
| Nelson, van denburg & campbell wealth management group | -5.00 |
| Northwestern mutual wealth management | -9.00 |
| Stephens consulting | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 216 | 0.47% | 55,383,162 | 4.20% | 111 | 0.94% | 110 | -9.84% | 78 | 23.81% |
| Mar 31, 2025 | 215 | 4.37% | 54,155,788 | 2.17% | 110 | 0.90% | 121 | 5.22% | 65 | 6.56% |
| Dec 31, 2024 | 194 | 5.43% | 43,660,980 | -17.71% | 91 | 0.74% | 109 | -3.54% | 56 | 40.00% |
| Sep 30, 2024 | 184 | 11.52% | 53,056,700 | -0.10% | 111 | 0.87% | 114 | 25.27% | 40 | -20.00% |
| Jun 30, 2024 | 165 | -5.17% | 53,108,448 | -0.23% | 113 | 0.88% | 91 | -3.19% | 50 | -3.85% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Gilead N | 1.43M | 2.89% | - |
| Vanguard US Total Market Shares ETF | 1.41M | 2.87% | 1.77K |
| Vanguard Total Stock Mkt Idx Inv | 1.34M | 2.68% | -28.37K |
| Eventide Healthcare & Life Sciences I | 1.09M | 2.20% | -80.92K |
| iShares Russell 2000 ETF | 1.02M | 2.05% | -19.43K |
| Polar Capital Biotech S Inc | 975.00K | 1.95% | - |
| MEDICAL BioHealth EUR Acc | 756.50K | 1.59% | - |
| Janus Henderson Global Life Sciences | 774.99K | 1.57% | 62.59K |
| Janus Henderson Global Life Sciences D | 774.99K | 1.55% | -3.15K |
| US Small-Cap Growth II Equity Comp | 716.26K | 1.45% | -40.98K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 11, 2025 | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Sell | - |
| Aug 11, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | $2.48M |
| Aug 07, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $580.00K |
| Aug 07, 2025 | Peetz Christopher | CHIEF EXECUTIVE OFFICER | Sell | $2.21M |
| Jul 03, 2025 | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sell | $23.41K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | 10 | 21 |
| 2024 Q4 | - | 1 |
| 2024 Q3 | 2 | 1 |
MIRM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools